Navigation Links
Men with Enlarged Prostate and BPH Have Improved Options with Introduction of Urolift Procedure and 4KScore Prostate Cancer Test for Evaluation of Elevated PSA

NEW YORK, Sept. 3, 2014 /PRNewswire-USNewswire/ -- Symptoms of enlarged prostate affect millions of men, who suffer needlessly from frequent urination and difficulty emptying their bladder. Urinary tract obstruction from BPH can cause dangerous bladder problems in men including urinary retention, UTI and kidney failure.

According to Dr. Alex Shteynshlyuger, Director of Urology at New York Urology Specialists, "men with urinary problems should see an experienced urologist. Early treatment can prevent unpleasant complications." He adds that with modern treatment options such as the Urolift system for BPH and Greenlight laser, "the benefits are often dramatic and side effects are limited."

Urolift System for BPH and Enlarged Prostate is a same-day procedure that effectively treats men with BPH symptoms with few sexual side-effects of common BPH treatment options. For men who are not candidates for Urolift, other treatment options including Greenlight Laser are available.

For more information, visit:

It is important to know that men with symptoms of enlarged prostate may have prostate cancer that can cause similar urinary symptoms.

Traditionally, the PSA test has been recommended for early detection of prostate cancer. Many men with mildly elevated PSA and symptoms of enlarged prostate do not have prostate cancer.

Recently, for men with elevated PSA, improved tests that include 4KScore as well as Prostate Health Index (PHI) have become available. These tests can replace the PSA test as they provide improved information and can help avoid unnecessary biopsies. 4K score prostate cancer test helps predict which men are more likely to have aggressive prostate cancer. 

About New York Urology Specialists

New York Urology Specialists is an independent urology practice offering state-of-the-art urology care for complex urological conditions including frequent urination in men, enlarged prostate and BPH, and prostate cancer care.

About Dr. Alex Shteynshlyuger

Dr. Alex Shteynshlyuger is a board-certified urologist who specializes in caring for men and women with complex urological problems. He serves as the Director of Urology at New York Urology Specialists. His research has been recognized nationally.  

For more information, visit New York Urology Specialists on Facebook and Google+

MEDIA CONTACT:  Dr. Alex Shteynshlyuger, 1-646-663-4252,,

Logo -

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
ProfNet -

SOURCE New York Urology Specialists
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
4. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
7. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
8. Breakthrough Prostate Cancer Diagnostics
9. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
10. Prostate Cancer and Bone Health
11. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
Breaking Medicine Technology:
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
Breaking Medicine News(10 mins):